Lotte Holdings | Lotte Healthcare and Biopharmaceutical CVC

corporate vcCo-invests

◆ Location

Japan

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Investment in Korean and global biotechnology companies, with focus on antibodies and antibody-drug conjugates (ADCs). First vehicle established August 2024 with ~10 investments across US, Japan, Taiwan, and Switzerland; second fund expected to close within a year with Korea as a new primary focus.

◆ About Lotte Holdings

LOTTE Holdings launched a healthcare and biopharmaceutical CVC to invest in biopharmaceuticals and next-generation modalities, with a stated goal of gathering cutting-edge insights and accelerating access to innovative technologies.[2] It targets startups globally and across all stages.[2][3]

◆ Sectors

BiotechDrug DiscoveryDiagnosticsMedtech

◆ Stages

pre-seedseedseries-a

◆ Geography Focus

JapanSouth KoreaSwitzerlandTaiwanUnited States

◆ Team

Name	Title	Role	Links
Genichi Tamatsuka	Representative Director & CEO	C-level

◆ Notable Investments

Physiologas TechnologiesMetaphore BiotechnologiesRakuten Medical

◆ Traits

Co-invests

◆ FAQ

What does Lotte Healthcare and Biopharmaceutical CVC invest in?

Lotte Healthcare and Biopharmaceutical CVC invests in Biotech, Drug Discovery, Diagnostics and Medtech at the pre-seed, seed and series-a stages.

Which geographies does Lotte Healthcare and Biopharmaceutical CVC focus on?

Lotte Healthcare and Biopharmaceutical CVC focuses on Japan, South Korea, Switzerland, Taiwan and United States, and is headquartered in Japan.